The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
929
August 19, 1994
View Complete Issue         Table of Contents 2019 
Oral Pilocarpine for Xerostomia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Oral Pilocarpine for Xerostomia
August 19, 1994 (Issue: 929)
Pilocarpine hydrochloride (Salagen- MGI Pharma), a cholinergic agonist long available in an ophthalmic formulation for treatment of glaucoma (Pilocar, and others), was recently approved by the US Food and Drug Administration (FDA) for oral...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Oral Pilocarpine for Xerostomia
Article code: 929c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.